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Abstract
Human and rat umbilical cord matrix mesenchymal stem cells (UCMSC) possess the ability
to control the growth of breast carcinoma cells. Comparative analyses of two types of
UCMSC suggest that rat UCMSC-dependent growth regulation is significantly stronger than
that of human UCMSC. Their different tumoricidal abilities were clarified by analyzing gene
expression profiles in the two types of UCMSC. Microarray analysis revealed differential
gene expression between untreated naïve UCMSC and those co-cultured with species-
matched breast carcinoma cells. The analyses screened 17 differentially expressed genes
that are commonly detected in both human and rat UCMSC. The comparison between
the two sets of gene expression profiles identified two tumor suppressor genes, adipose-
differentiation related protein (ADRP) and follistatin (FST), that were specifically up-regulated
in rat UCMSC, but down-regulated in human UCMSCwhen they were co-cultured with the
corresponding species’ breast carcinoma cells. Over-expression of FST, but not ADRP, in
human UCMSC enhanced their ability to suppress the growth of MDA-231 cells. The growth
of MDA-231 cells was also significantly lower when they were cultured in medium condi-
tioned with FST, but not ADRP over-expressing human UCMSC. In the breast carcinoma
lung metastasis model generated with MDA-231 cells, systemic treatment with FST-over-
expressing human UCMSC significantly attenuated the tumor burden. These results suggest
that FSTmay play an important role in exhibiting stronger tumoricidal ability in rat UCMSC
than human UCMSC and also implies that human UCMSC can be transformed into stronger
tumoricidal cells by enhancing tumor suppressor gene expression.
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Introduction
Umbilical cord matrix mesenchymal stem cells (UCMSC) are derived from the gelatinous con-
nective tissue of the umbilical cord, Wharton’s jelly. UCMSC exhibit primitive stem cell char-
acteristics which include self-renewability and multipotency. They express similar stem cell
markers with those expressed in bone marrow derived mesenchymal stem cells [1]. UCMSC
can differentiate into cardiomyocytes, neuron-like cells, osteocytes, endothelial cells, and pan-
creatic islet-like cell clusters [2–4].
Mesenchymal stem cells including UCMSC home to inflammatory regions including can-
cers, which makes them useful as virus or nanoparticle-loaded gene or drug carriers [5,6]. Re-
cent findings show that naïve human or rat UCMSC suppress the growth of several kinds of
tumors [7–9]. Rat naïve UCMSC completely abolished the growth of rat mammary tumors
without recurrence for 100 days [7]. The growth of pancreatic and lung cancer xenografts were
also significantly suppressed by rat UCMSC therapy in immunocompetent mice [8,9]. The
in vitro studies showed a decrease in breast cancer cell growth by indirect co-culture of naïve
UCMSC and breast cancer cells [10]. Conditioned medium with naïve UCMSC also suppressed
the growth of breast, lung, and pancreatic cancer cells [8–10]. Although the mechanisms by
which naïve UCMSC suppress the tumor growth is not fully elucidated, a few potential mecha-
nisms have been proposed; UCMSC produce transmissive factors and cause cell cycle arrest
and apoptosis in tumor cells; they activate anti-tumor immune responses in cancer-bearing an-
imals [9–13]. It is also suggested that naïve UCMSC communicate with adjacent cancer cells by
exchanging chemical signals with each other: this communication is most likely mediated by
cytokines and growth factors. However, this cytokine or growth factor-mediated communica-
tion is not fully clarified.
On the other hand, although both human and rat naïve UCMSC can suppress tumor
growth, the tumor growth inhibition by human UCMSC is not as strong as that of rat UCMSC.
In [3H]-Thymidine uptake assay, a small number of rat UCMSC (1:15) suppressed the growth
of rat breast carcinoma cells more than 90%, whereas a much higher number of human
UCMSC (1:2) suppressed only 50% of the growth of human breast cancer cells [7,10]. This dif-
ference in cell growth inhibition may suggest that the two types of UCMSC exhibit fundamen-
tal differences in cell-to-cell communication by cytokines and growth factors.
Accordingly, the present study was conducted to discover the key mechanisms by which rat
and human UCMSC attenuate tumor growth by defining UCMSC-produced cytokines and
growth factors. To conduct this study, we hypothesized that; 1) human and rat UMCSC express
genes differently when they co-exist with breast carcinoma cells; 2) tumoricidal activities of
human and rat UCMSC are dependent on differentially expressed genes and their products; 3)
expression manipulation of identified rat UCMSC tumoricidal genes in human UCMSC will
generate human UCMSC armed with enhanced tumoricidal ability. Proving these hypotheses
may represent the molecular mechanism by which naïve UCMSC inhibit tumor growth. Fur-
thermore, this principle can be applied to generate strongly tumoricidal human UCMSC for
breast cancer treatment.
Materials and Methods
Cell culture
Human and rat UCMSC were prepared fromWharton’s jelly, which is the matrix of the umbil-
ical cord, as previously described [1,2,7,14]. Practically, the cords were collected by hospital’s
medical personnel under the supervision of the gynecologist and were given with no donor-
identifying information. The informed consent procedure was handled by hospital staff so that
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the donors were informed of the potential use of their umbilical cords for medical research [2].
Additionally, we were assured that the cords were free from known infectious diseases. The
human biological samples were sourced ethically and their research use was approved by the
Kansas State University Institutional Review Board (Protocol # 3515). UCMSC were main-
tained in a defined medium, containing a mixture of 56% low glucose Dulbecco’s Modified
Eagle Medium (DMEM; Life Technologies, Grand Island, NY), 37%MCDB 201 (Sigma,
St. Louis, MO), 2% fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville, GA), 1x insu-
lin-transferrin-selenium-X (Life Technologies), 1x ALBUMax I (Life Technologies), 1x penicil-
lin/streptomycin (Life Technologies), 10nM dexamethasone, 100μM ascorbic acid
2-phosphate, 10ng/ml epidermal growth factor, and 10ng/ml platelet derived growth factor-bb
(all from Sigma, St. Louis, MO). MDA-231 human mammary adenocarcinoma cell line, kindly
provided by Dr. F. Marini (M.D. Anderson Cancer Center, TX), were maintained in Minimum
Essential Media (MEM) alpha medium (Life Technologies) supplemented with 10% FBS, 1x
penicillin/streptomycin, 1% non-essential amino acids, and 1% L-glutamine. The Mat B III rat
mammary adenocarcinoma cell line was purchased from American Type Culture Collection
(Manassas, VA). The Mat B III cells were maintained in McCoy's 5A modified medium (Life
technologies) supplemented with 10% FBS and 1x penicillin/streptomycin. All of the cell lines
were maintained at 37°C in a humidified atmosphere containing 5% CO2.
Co-culture and RNA isolation
An indirect cell culture using Transwell culture dishes (Corning Inc., Lowell, MA) was per-
formed to collect RNA samples for microarray study. In brief, human (5x104 cells) or rat
(1x105 cells) UCMSC were seeded in defined medium in the bottom of a 6-well or 10cm Trans-
well culture dish, respectively. After allowing UCMSC to settle for 24 hours at 37°C in a humid-
ified incubator at 5% CO2, MDA-231 cells (5x10
5 cells) or Mat B III cells (1.5x106 cells) were
added in Transwell inserts (0.4μm pore size). Naïve UCMSC were cultured in identical condi-
tions as the co-cultured UCMSC without carcinoma cell addition to the inserts. After 48 hours
at 37°C, total RNA was extracted from naïve UCMSC or UCMSC co-cultured with carcinoma
cells using TRIzol following the manufacturer’s instruction (Life Technologies). Concentration
and quality of total RNA were determined by the NanoDrop ND-8000 spectrophotometer
(NanoDrop Technologies, Inc., Wilmington, DE) and Agilent 2100 bioanalyzer (Agilent Tech-
nologies, Inc. Santa Clara, CA), respectively.
Microarray and data analysis
Microarray experiments including RNA quality evaluation, hybridization, and initial data anal-
ysis were carried out at the National Institute on Aging, National Institutes of Health (Balti-
more, MD) according to previously described methods [15]. The data are held in the Gene
Expression Omnibus (GEO) database under accession #GSE64839. Detailed methods for mi-
croarray experiments have been described elsewhere [12]. The microarray dataset was analyzed
with DIANE 6.0, a spreadsheet-based microarray analysis program, as described previously
[12,15]. The DIANE microarray analysis program can be found online at http://www.grc.nia.
nih.gov/branches/rrb/dna/diane_software.pdf.
Quantitative real-time PCR (qRT-PCR)
The expression of adipose-differentiation related protein (ADRP) and follistatin (FST) in mi-
croarray analysis were reevaluated by qRT-PCR using the same RNA samples as those used for
the microarray. qRT-PCR was carried out using the iScript One-Step RT-PCR Kit with SYBR
Green (Bio-Rad, Hercules, CA), and the reactions were conducted on the StepOnePlus Real-
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Time PCR System (Applied Biosystems). The qRT-PCR was performed as follows: a 10 min
initial incubation at 50°C was followed by 45 cycles of 10 seconds at 95°C, 20 seconds at 58°C,
and 50 seconds at 72°C, followed by final extension at 72°C for 4 min. The results were quanti-
fied by the comparative Ct method [16]. The sequences of primers used are described in
Table 1.
Adenovirus construction and transduction
Green fluorescent protein(GFP)-tagged adenoviral vectors for human ADRP (Ad-ADRP) and
FST (Ad-FST) genes were constructed using human ADRP and FST cDNA plasmids from
Open Biosystems (Huntsville, AL) by Vector Biolabs (Philadelphia, NJ). Adenovirus encoding
β-galactosidase (Ad-LacZ) gene was prepared as described previously [18]. Adenoviral vectors
were expanded and titred by following the BD Adeno-X Expression system manual (Clontech
Laboratories, Inc, Mountain View, CA). The gene transduction to human UCMSC was carried
out by following the procedure described in the previous study [19]. Transduction efficiencies
of Ad-ADRP and Ad-FST to the human UCMSC were determined by qRT-PCR as described
above. GFP expression of gene transduced UCMSC was observed under a
fluorescent microscope.
Evaluation of the effect of ADRP or FST over-expressing human
UCMSC on the growth of MDA-231 cells in co-culture
The effect of ADRP or FST over-expressing human UCMSC on the growth of MDA-231 cells
was evaluated by direct co-culture and 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay. Human UCMSC transduced with Ad-ADRP, Ad-FST, or Ad-LacZ in
50 multiplicity of infection (MOI) were seeded (1,250 cells/well) in a 24-well plate and incubat-
ed at 37°C in a humidified, 5% CO2 incubator allowed to attach to the plate. Twenty-four
hours later, MDA-231 cells (12,500 cells/well) were seeded directly into the wells containing
gene transduced human UCMSC and co-cultured for 48 hours at 37°C. The total cell prolifera-
tion of MDA-231 cells and co-cultured human UCMSC was quantified by MTT assay as de-
scribed previously [18].
Evaluation of the effect of conditioned medium obtained from
engineered human UCMSC on the growth of human breast carcinoma
cells
The effect of conditioned media collected from human UCMSC transduced with ADRP or FST
gene on the growth of MDA-231 cells was evaluated by conventional cell culture and MTT
assay. Un-conditioned defined medium was used as control. In brief, Ad-ADRP,-FST or-LacZ
(50 MOI) were transduced on human UCMSC. The media conditioned with various engi-
neered human UCMSC were collected after 48 hours of incubation and diluted with defined
medium in a 1:1 ratio. MDA-231 cells seeded in 96 well plates (2000 cells/well) were incubated
Table 1. Primers used for qRT-PCR.
Species Genes Forward (5’-3’) Reverse (5’-3’) References
Human ADRP CTCATGGGTAGAGTGGAA-AAGGAGCATTGG TTGGATGTTGGACAGGAG-GGTGTGGCACGT [17]
FST TGTGCCCTGACAGTAAGTCG GTCTTCCGAAATGGAGTTGC This study
Rat Adrp CATTCAAGACCAGGCCAAAC AGGAGGTAACATTGCGGAAC This study
Fst TGCTGCTACTCTGCCAATTC TGCAACACTCTTCCTTGCTC This study
doi:10.1371/journal.pone.0123756.t001
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for 24 hours, and then cultured for 48 hours in various conditioned media. Cell proliferation of
MDA-231 cells was quantified by MTT assay as described previously [18].
Evaluation of the effect of ADRP or FST over-expression in human
breast carcinoma cells on formation and growth of colonies
Two layer-colony forming assay was carried out as a three dimensional colony growth of
human breast carcinoma cells by following the method described previously [10]. Briefly,
0.5 ml of 0.9% agar (Sea Plaque agarose, Cambrex Bio Science Rockland, Inc. Rockland, ME)
in MEM αmedium supplemented with 10% FBS was poured into the wells of a 12-well tissue
culture plate as a bottom layer. After solidification, 25,000 MDA-231 cells transduced with
50 MOI Ad-ADRP,-FST or-LacZ were suspended in 0.5ml 0.5% agarose in MEM αmedium
containing 10% FBS and layered over the bottom layer. The cells were incubated at 37°C with
5% CO2 for growth of colonies. On days 7 and 12, colony growth was evaluated by an automat-
ed phase contrast microscope equipped with Micro Analysis Suite (Olympus CKX41, Center
Valley, PA). Colonies with an area greater than 5,000 μm2 were counted using Micro Suite Five
software. The ratio of colony growth of MDA-231 cells was determined between days 7 and 12.
Evaluation of the effect of FST over-expressing human UCMSC on
human breast carcinoma cell metastasis in mouse lungs
All animal experiments were carried out under strict adherence with the Kansas State Universi-
ty Institutional Animal Care and Use Committee (IACUC) protocol. The protocol was ap-
proved by the Kansas State University IACUC (Protocol # 3015) and Institutional Biosafety
Committee. All mice were sacrificed under isofluorane anesthesia and all efforts were made to
minimize suffering. Sixteen severe combined immunodeficiency (CB17/SCID) mice obtained
from Charles River (Wilmington, MA) were housed in an animal care facility and held for
10 days to acclimatize. Each mouse was injected with 2x106 MDA-231 cells through the tail
vein. Six days after cancer cell inoculation, mice were randomly divided into three treatment
groups; (1) phosphate buffered saline (PBS; n = 5) as a no-treatment control; (2) FST over-
expressing human UCMSC (n = 6); or (3) LacZ over-expressing human UCMSC (n = 5) as a
control for adeno-virus transduced UCMSC. On days 6, 13, and 20 after the MDA-231 cell in-
oculation, mice were injected intravenously with 200μl PBS, FST or LacZ over-expressing
human UCMSC (5x105 cells/mouse) in 200μl PBS. The mouse body weights were monitored
every other day. Four weeks after MDA-231 cell transplantation, all mice were sacrificed and
major organs including brains, lungs, livers, kidneys, and mesenteries were examined for their
potential tumor growth. Numbers of tumor nodules in the lungs were counted under stereomi-
croscope. The in-vivo experiment was conducted one time.
Histological analysis of cell proliferation and apoptosis in metastatic lung
tumors
Lungs were fixed in 10% buffered-formalin, paraffin embedded and sectioned at 4μm for histo-
logical analysis. After deparaffinization of sections, heat-induced epitope unmasking was per-
formed in citrate buffer followed by incubation with 3% H2O2/methanol for 5 minutes to block
endogenous peroxidase activity. To analyze cell proliferation in tumors, sections were immu-
nostained with Ki-67 (1:100; Catalog #: ab15580, Abcam, Cambridge, MA) for 1 hour at 37°C
then treated with a biotin-conjugated anti-rabbit IgG antibody (1:100; Catalog #: BA-1000,
Vector Laboratories, Burlingham, CA) for 1 hour at 37°C. Sections were then treated with the
avidin-biotin-peroxidase complex reagent (Vector Laboratories, Burlingham, CA) for 40
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minutes at 37°C. Reactions were developed with 3,3'-diaminobenzodine tetrahydrochloride
(Sigma, St. Louis, MO) and counterstained lightly with Mayer`s hematoxylin. To determine ap-
optosis in tumors, a terminal deoxynucleotidyl transferase—mediated dUTP nick end labeling
(TUNEL) assay was conducted using the DeadEnd Colorimetric TUNEL System (Catalog #:
G7130, Promega, Madison, WI), according to the manufacturer's instructions with a slight
modification [20]. The percentage of Ki-67 positive cells area and the absolute number of
TUNEL positive cells in the 5 randomly selected tumor area were measured for the cell prolif-
eration index and apoptotic index, respectively, by ImageJ software.
Statistical analysis
All values are expressed as means ± standard error (S.E.) for all in vitro and in vivo experi-
ments. Statistical significance was assessed by one-way ANOVA following Tukey's test or t-
test. Statistical significance was set at p< 0.05.
Results
Differential gene expression in human and rat UCMSC by microarray
analysis
The characteristics of human and rat UCMSC are described previously [2,7]. Differentially ex-
pressed genes in human or rat naïve UCMSC and those co-cultured with corresponding spe-
cies’mammary carcinoma cells were determined by genome-wide microarray analysis as
described in the Method section (Accession #GSE64839). Uniquely expressed genes were fur-
ther screened by the following three criteria; 1) gene expression difference should be at least 1.5
fold different between naïve UCMSC and those co-cultured with breast carcinoma cells; 2) the
genes must encode secretory proteins; and 3) the genes are associated with cell growth regula-
tion. By the analysis of z-normalization of the hybridization signals, 43 genes were selected in
human UCMSC and 64 genes were selected from rat UCMSC. By comparing these selected
genes between human and rat UCMSC, 17 genes were discovered to be commonly expressed in
both UCMSC (Fig 1). Eight of these genes were up-regulated in both human and rat UCMSC.
Two genes were up-regulated in rat UCMSC but down-regulated in human UCMSC, while the
other seven genes were up-regulated in human UCMSC but down-regulated in rat UCMSC
(Fig 2). Furthermore, eight genes were reported as tumor suppressor genes and five genes were
reported as tumor promoter genes while the other four genes are related to cell growth but
their functions in tumor growth are unknown (Table 2). Two tumor suppressor genes, ADRP
and FST, which were up-regulated in rat UCMSC but down-regulated in human UCMSC were
further characterized as potential candidate genes to exhibit stronger tumoricidal activity in rat
UCMSC than in human UMCSC. The mRNA expressions of ADRP and FST in human and rat
UCMSC were further verified by qRT-PCR. Both ADRP and FST mRNA expressions were
consistently up-regulated in rat UCMSC co-cultured with Mat B III cells (8.5 ± 0.3 and
1.8 ± 0.05 folds, respectively). In human UCMSC co-cultured with MDA-231 cells, although
FST mRNA expression was down-regulated (0.4 ± 0.1 fold) as observed in the microarray
study, ADRP expression was up-regulated (2.7 ± 0.3 fold).
Human UCMSC over-expressing FST inhibited the growth of MDA-231
cells in vitro
To evaluate the effects of ADRP or FST over-expression in human UCMSC on breast carcino-
ma cell growth, adenoviral vectors encoding ADRP (Ad-ADRP) and FST (Ad-FST) were indi-
vidually constructed using GFP encoding expression vector. Gene transduction by Ad-ADRP
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or Ad-FST was confirmed by observing GFP co-expression in the cells. A good even expression
of GFP was detected in human UCMSC under a fluorescent microscope when they were trans-
duced with 50 MOI vectors.
The effect of Ad-FST transduced human UCMSC (FST-hUCMSC) on the growth of MDA-
231 cells was evaluated by direct co-culture of the two types of cells in 2D cultures. As shown in
Fig 3A, direct co-culture of FST, but not ADRP, transduced human UCMSC (ADRP-
hUCMSC) with MDA-231 cells (1:10 ratio) decreased the overall cell growth significantly.
Fig 1. Clustering analysis of significant genes in rat UCMSC (rUCMSC) and human UCMSC (hUCMSC)
co-cultured with mammary carcinoma cells of their respective species; Mat B III rat breast carcinoma
cells or MDA-231 human breast carcinoma cells. The genes differentially expressed between naïve
human or rat UCMSC and those co-cultured with mammary carcinoma cells are listed on the row and the
samples are shown on the column. Red are higher expression and black to green are lower expression. This
analysis suggests that a short time co-culture with mammary carcinoma cells significantly modifies
expression of multiple tumor-suppressor and-promoter genes in both human and rat UCMSC.
doi:10.1371/journal.pone.0123756.g001
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Fig 2. Z ratios of the 17 commonly expressed genes in both hUCMSC and rUCMSC co-cultured with breast carcinoma cells. The solid bars indicate
gene expression in hUCMSC and the white bars indicate gene expression in rUCMSC.
doi:10.1371/journal.pone.0123756.g002
Table 2. Function and expression levels of differentially expressed genes in human and rat UCMSC.
Tumor promoter genes1 Rat Human Ref. Tumor suppressor genes2 Rat Human Ref.
PTGS2 (COX2) + + [30] SULF1 + + [12,31]
SERPINE2 + + [32,33] GPI + + [12]
MIF + + [29] HTRA1 + + [34]
PDPN - + [35] ADRP + - [12,27]
TGFBI - + [36] FST + - [21]
Function unknown genes3 Rat Human LTBP4 + - [37,38]
P4HA1, COL1A2, + + BGN + - [39]
PAM, PDIA5 - + LOXL1 + - [40]
Positive (+) indicates upregulation and negative (-) indicates down regulation.
1 PTGS2 (COX2), prostaglandin-endoperoxide synthase 2, SERPINE2, serpin peptidase inhibitor clade E, MIF, macrophage migration inhibitory factor,
PDPN, podoplanin, TGFBI, transforming growth factor, beta-induced, 68kDa.
2 SULF1, sulfatase 1, GPI, glucose-6-phosphate isomerase, HTRA1, HtrA serine peptidase 1, ADRP, adipose-differentiation related protein, FST,
follistatin, LTBP4, latent transforming growth factor beta binding protein 4, BGN, biglycan, LOXL1, lysyl oxidase-like 1.
3 P4HA1, prolyl 4-hydroxylase, alpha polypeptide I, COL1A2, collagen, type 1, alpha2, PAM, peptidylglycine alpha-amidating monooxygenase, PDIA5,
protein disulﬁde isomerase family A, member 5.
doi:10.1371/journal.pone.0123756.t002
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Fig 3. The growth of MDA-231 cells was significantly attenuated by co-culture with FST-hUCMSC (A),
the conditioned medium from FST-hUCMSC (B), or by direct over-expression of FST (C). A, MDA-231
Tumor Suppressor Gene Expression in UCMSC
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Furthermore, to evaluate indirect effect of the gene transduced human UCMSC on the growth
of MDA-231 cells, MDA-231 cells were cultured with the conditioned medium obtained from
gene transduced UCMSC and the growth of MDA-231 cells was evaluated by MTT assay
(Fig 3B). The growth of MDA-231 cells was significantly attenuated when cultured with the
conditioned medium from FST-hUCMSC as compared to that cultured in LacZ transduced
human UCMSC (LacZ-hUCMSC). However, the conditioned medium from ADRP-hUCMSC
showed only a slight decrease in cell growth. The experiment utilizing the conditioned medium
supports the idea that FST appears to be secreted in the culture medium and UCMSC depen-
dent cell growth attenuation is at least in part mediated through proteins secreted from the
UCMSC.
In the 3D co-culture in which MDA-231 cells were cultured in 0.4% soft agar gel, the colony
size and numbers of FST transduced, but not LacZ, or ADRP transduced MDA231 cells were
significantly inhibited 12 days after gene transduction (Fig 3C). These results suggest that the
FST expression in MDA-231 cells also inhibits cell growth in autocrine and paracrine manners.
On the other hand, the inhibitory effect of the ADRP gene on tumor growth was negligible in
the present study (Fig 3). This very weak tumor growth regulation of ADRP may be associated
with ADRP-dependent cell differentiation of UCMSC. In support of this idea, a significant
lipid accumulation was observed when human UCMSC were transduced with ADRP (S1 Fig).
Human UCMSC transduced with FST inhibited growth of MDA-231
xenografts in mice
To further evaluate the significance of the FST gene in tumor growth inhibition, FST-hUCMSC
was tested to determine whether FST-hUCMSC attenuated the growth of MDA-231 grafts in a
breast cancer lung metastasis model. For this in vivo mouse study, a lung metastasis model of
MDA-231 breast carcinoma cells was used since the lung is one of the most prominent sites of
breast cancer metastasis and this model is reproducible. Three weekly treatments with half a
million FST-hUCMSC significantly attenuated metastatic tumor growth in the lung; the tumor
nodule number in the FST-hUCMSC treated mouse lungs obtained one week after the third
treatment was significantly smaller than those in LacZ-hUCMSC or PBS treated mouse lungs
(Fig 4). No tumors were observed in other organs including brain, liver, kidney, and mesentery.
These results clearly suggest that FST expression in human UCMSC play a critically important
role in suppressing tumor growth in mice.
Histological analysis of cell proliferation and apoptosis in metastatic lung
tumors
Cell proliferation and apoptosis of the metastatic tumor cells in the lungs were analyzed histo-
logically. Immunohistochemical analysis of Ki-67 positive cells indicated that the treatment
with either the LacZ- or the FST-hUCMSC slightly decreased the proliferation of tumor cells in
cells were co-cultured with either LacZ-, ADRP- or FST-hUCMSC for 48 hours. Cell growth was measured by
MTT assay (panels A and B). Transduction of hUCMSCwith adenoviral vector did not affect the cell growth.
FST-hUCMSC, but not ADRP-hUCMSC significantly attenuated the growth of co-cultured carcinoma cells to
the same level of MDA-231 cells cultured alone. B, the growth of MDA-231 cells was significantly attenuated
by culturing with the conditioned medium (CM) from Ad-FST but not-LacZ or-ADRP transduced human
UCMSC or defined medium (DM). C, the growth of MDA-231 cells was significantly attenuated by the direct
transduction of Ad-FST but not by-LacZ or-ADRP. The colony growth rate of the FST-transduced MDA-231
cells from Day 7 to 12 was 1.02 (no growth), while the other gene-transduced cells colonies grew
approximately 1.5 times bigger on Day 12 compared to Day 7. * p < 0.05.
doi:10.1371/journal.pone.0123756.g003
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the lungs without statistical significance (Fig 5). Apoptotic cells detected as TUNEL positive
cells were located primarily in the tumor area. The number of TUNEL positive cells increased
in the two treatment groups, but only the FST-hUCMSC treated group showed a significant in-
crease in apoptotic cell numbers as compared to the PBS-treated group (p< 0.05, Fig 5). These
results suggest that FST- hUCMSC treatment attenuated the growth of MDA-231 metastatic
lung tumors mainly by increasing apoptosis and that this growth attenuation was significantly
enhanced by the over-expression of the FST gene in hUCMSC.
Discussion
The current study discovered the changes of expression patterns in tumor suppressor genes in
rat and human UCMSC when they were co-cultured with carcinoma cells. Our previous study
had revealed that gene expression pattern in rat UCMSC was significantly altered when they
were co-cultured with rat breast carcinoma cells [12]. However, whether similar alteration of
gene expression in rat UCMSC is also observed in human UCMSC when they are co-cultured
with human breast carcinoma cells is unclear. In addition, although previous investigations in
the tumoricidal activities of human and rat UCMSC had suggested that rat UCMSC have a
stronger tumoricidal activity than human UCMSC [7,10], the molecular mechanisms by which
rat UCMSC strongly attenuate the species specific growth of breast carcinoma more than
human UCMSC do were unclear. Since two types of UCMSC have significant carcinoma cell
growth suppressing abilities in an indirect co-culture [7,10], it is suggested that UCMSC-
dependent inhibition of breast carcinoma cell growth is partially due to secreted proteins. Con-
sequently, we hypothesized that a comparison of gene expression profiles in human and rat
Fig 4. Treatment with FST-hUCMSC significantly attenuated development of metastatic tumor in the mouse lung. The numbers of tumor nodules in
the mouse lung were counted under a dissection microscope 30 days after the inoculation of the MDA-231 cells. The bar graph represents the average
number of tumor nodules in each treatment group. * p < 0.05 compared to LacZ-hUCMSC treated mice.
doi:10.1371/journal.pone.0123756.g004
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Fig 5. Immunohistochemical analysis of cell proliferation (A and B) and apoptosis (A and C) in MDA-
231 graft tumors in SCIDmouse lungs treated with either PBS, LacZ- or FST-hUCMSC. A, microscopic
images of immunohistochemistry for Ki-67 (top 3 panels) at 20x and TUNEL assay (bottom 3 panels) at 40x.
Tumor Suppressor Gene Expression in UCMSC
PLOSONE | DOI:10.1371/journal.pone.0123756 May 5, 2015 12 / 17
UCMSC co-cultured with breast carcinoma cells may provide the identity of the key players for
the differential tumoricidal abilities in two types of UCMSC. Furthermore, an identification of
the key mechanisms in rat UCMSC-dependent strong tumoricidal activity can be utilized to re-
inforce human UCMSC-dependent tumoricidal activity to the rat UCMSC level. In the present
study, two tumor suppressor genes, ADRP and FST were found to be upregulated in rat
UCMSC, whereas these two genes were down regulated in human UCMSC when two types of
UCMSC were co-cultured with corresponding species’ breast carcinoma cells. Therefore, ex-
pression differences of these two genes in two types of UCMSC and their biological functions
may explain the differential tumoricidal activities of UCMSC.
FST, which is known as an activin-binding protein, suppress the metastasis of small cell
lung carcinoma [21]. FST inhibits the bioactivity of activin A, a TGF beta family protein, which
is associated with lung adenocarcinoma proliferation in human patients [22]. However, the ef-
fect of activin A on breast cancer cells is still controversial [23,24]. FST over-expressing human
UCMSC significantly reduced the growth of MDA-231 cells in direct and indirect co-cultures
(Fig 3) which is consistent with the previous study used different cancer models [21]. Trans-
duction of FST with MDA-231 cells also significantly suppressed the colony growth of MDA-
231 cells in the colony assay (Fig 3C). Furthermore, the metastatic tumor growth of MDA-231
cells in the lung was significantly attenuated by treatment with FST-hUCMSC in mice (Fig 4).
These results clearly indicate that FST expression plays a significant role in human and rat
UCMSC-dependent tumoricidal activities. Indeed, a significantly higher number of apoptotic
cells were detected in the FST over-expressing human UCMSC treated group (Fig 5). These re-
sults are consistent with previous reports that FST overexpression induces apoptosis in human
and mouse breast carcinoma cells [25,26]. Furthermore, the anti-tumor effect shown here may
also be associated with pro-apoptotic factors produced by naïve human UCMSC [10]. As re-
ported by Ayuzawa et al. [10], the attenuation of Akt and MAPK pathways might also have a
role in attenuating the tumor cell proliferation when human UCMSC are co-cultured with
breast carcinoma cells.
ADRP has been reported as a prognosis marker of clear cell renal cell carcinoma [27]. Pa-
tients with higher expression of ADRP in clear cell renal cell carcinoma tissues had a longer
survival rate than those showing lower expression [27]. Although ADRP over-expression in rat
UCMSC significantly increased their growth inhibition effect against rat mammary carcinoma
cells [12], their direct or indirect tumor suppressing effect against human breast carcinoma
cells was not significant (Fig 3). Although the causes of functional differences between ADRP
expressions in human and rat UCMSC are unclear, ADRP-dependent cell differentiation is po-
tentially associated with this difference in two types of UCMSC. ADRP expression is shown to
be associated with pre-adipocyte differentiation in several cell types [28]. Indeed, lipid accumu-
lation was observed when human UCMSC were transduced with ADRP (S1 Fig). Therefore, it
is conceivable that the initiation of adipocyte differentiation was easily induced by ADRP over-
expression in human UCMSC, which may have weakened their tumoricidal ability, whereas
adipocyte differentiation was not induced in rat UCMSC by ADRP over-expression. Further
clarification is required on this issue.
As we hypothesized, human and rat UCMSC showed different gene expression profiles
(Figs 1 and 2). A comparison of the two gene expression profiles suggests that high expression
B, treatment with LacZ- or FST-hUCMSC had no significant effect on proliferation of the tumor cells. C, the
TUNEL positive cells were significantly increased in the tumors of mice treated with FST-hUCMSC.
* p < 0.05 as compared to the level of the PBS-treated control.
doi:10.1371/journal.pone.0123756.g005
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of two putative tumor suppressor genes in rat UCMSC may be associated with strong tumorici-
dal activity (Fig 2). Over-expression of one such gene, FST, in human UCMSC caused a signifi-
cant suppression of the growth of MDA-231 cells in both cell culture and mouse studies.
Although the complete depletion of the tumors was not observed by the treatment with FST-
over-expressing human UCMSC (Fig 4), this study suggests that upregulation of multiple
tumor suppressor genes in UCMSC is involved in both human and rat UCMSC-dependent
tumor growth suppression.
The microarray analysis also indicated an upregulation of three tumor promoter genes pros-
taglandin-endoperoxide synthase 2 (PTGS2), serpin peptidase inhibitor, clade E, member 2
(SERPINE2), and macrophage migration inhibitory factor (MIF) in both human and rat
UCMSC when they were co-cultured with breast carcinoma cells. Among these genes, extracel-
lular MIF has been shown to act as a pro-oncogene in breast cancer [29]. Since UCMSC de-
rived MIF might play a role as a pro-oncogene, MIF receptor expression in MDA-231 cells and
Mat B III cells was investigated. MDA-231 cells have a significant level of MIF receptor expres-
sion [29], whereas our microarray data showed that Mat B III cells co-cultured with rat
UCMSC did not exhibit a significant increase of MIF receptor expression which implies Mat B
III cells are less sensitive to pro-oncogene, MIF. These data suggest different tumoricidal abili-
ties of human and rat UCMSC might also be due to different sensitivities of the different breast
carcinoma cells to tumor promoter proteins produced by either UCMSC. In other words, Mat
B III cells are poorly sensitive to tumor promoters due to the poor receptor expression, whereas
MDA-231 cells are more sensitive due to a high receptor expression for tumor promoters. A
view from the regulation of the tumor promoter genes also provided a molecular mechanism
of differential tumoricidal abilities of two types of UCMSCs. These results also indicate that an
investigation in different combinations of human UCMSC and cancer cells is important in
order to fully understand UCMSC-dependent tumoricidal activity. The present study warrants
the importance of additional studies to clarify such an issue.
In conclusion, the intrinsic tumoricidal ability of UCMSC is a very unique attribute. The pres-
ent study indicates that human and rat UCMSC-dependent carcinoma cell growth suppression is
due at least in part to the expression modulation of multiple tumor suppressor and promoter
genes. This is the first study to describe potential use of human UCMSC engineered to express an
endogenous tumor suppressor gene for breast cancer treatment. This study clearly indicates that
engineering human UCMSC by endogenous tumor suppressor genes can re-enforce UCMSC-de-
pendent tumoricidal ability. It is apparent that generation of more effective human UCMSC re-
quires further studies for efficient cell preparation and long-lasting gene transduction methods.
Supporting Information
S1 Fig. Transduction of Ad-ADRP into hUCMSC induced lipid accumulation in the cyto-
plasm of the cells. Naïve human UCMSC (a) were transduced by 100 MOI Ad-LacZ (b) 50
MOI (c) and 100 MOI (d) Ad-ADRP. Seven days after transduction, cells were stained by
Sudan-black. Human UCMSC transduced with Ad-LacZ showed a negligible amount of oil
droplets. In contrast, Ad-ADRP transduction induced a large amount of lipid accumulation in
human UCMSC.
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Acknowledgments
The authors acknowledge Dr. Frank Marini (MD Anderson Cancer Center, University of
Texas, Houston, TX) for his generous contribution of MDA-231 cells. We thank Ms. Katie
Tumor Suppressor Gene Expression in UCMSC
PLOSONE | DOI:10.1371/journal.pone.0123756 May 5, 2015 14 / 17
Turner (Department of Anatomy & Physiology, Kansas State University) for critical reading
and constructive comments during the preparation of the manuscript.
Author Contributions
Conceived and designed the experiments: NOMT. Performed the experiments: NO SI AK DU
MP SD YZMT. Analyzed the data: NO SI AK DU SD YZ. Contributed reagents/materials/
analysis tools: MP DT SD YZ KGB. Wrote the paper: NO SI DUMT.
References
1. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, et al. Mesenchymal stem cells in the
Wharton's jelly of the human umbilical cord. Stem Cells. 2004; 22: 1330–1337. PMID: 15579650
2. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord
matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkin-
son's disease. Stem Cells. 2006; 24: 781–792. PMID: 16223852
3. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of
fetus-derived stem cells. Stem Cells. 2007; 25: 2886–2895. PMID: 17690177
4. Chao KC, Chao KF, Fu YS, Liu SH. Islet-like clusters derived frommesenchymal stem cells in Whar-
ton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS ONE. 2008;
3: e1451. doi: 10.1371/journal.pone.0001451 PMID: 18197261
5. Venkatesan JK, Ekici M, Madry H, Schmitt G, Kohn D, Cucchiarini M. SOX9 gene transfer via safe, sta-
ble, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to en-
hance the chondrogenic potential of humanmesenchymal stem cells. Stem Cell Res Ther. 2012; 3(3):
22. doi: 10.1186/scrt113 PMID: 22742415
6. Auffinger B, Morshed R, Tobias A, Cheng Y, Ahmed AU, Lesniak MS. Drug-loaded nanoparticle sys-
tems and adult stem cells: a potential marriage for the treatment of malignant glioma? Oncotarget.
2013; 4: 378–396. PMID: 23594406
7. Ganta C, Chiyo D, Ayuzawa R, Rachakatla R, Pyle M, Andrews G, et al. Rat umbilical cord stem cells
completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days
post-tumor cell inoculation. Cancer Res. 2009; 69: 1815–1820. doi: 10.1158/0008-5472.CAN-08-2750
PMID: 19244122
8. Doi C, Maurya DK, Pyle MM, Troyer D, Tamura M. Cytotherapy with naive rat umbilical cord matrix
stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in
syngeneic mice. Cytotherapy. 2010; 12: 408–417. doi: 10.3109/14653240903548194 PMID: 20345214
9. Maurya DK, Doi C, Kawabata A, Pyle MM, King C, Wu Z, et al. Therapy with un-engineered naive rat
umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma. BMCCancer.
2010; 10: 590. doi: 10.1186/1471-2407-10-590 PMID: 21029413
10. Ayuzawa R, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D, et al. Naive human umbilical cord
matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo.
Cancer Lett. 2009; 280: 31–37. doi: 10.1016/j.canlet.2009.02.011 PMID: 19285791
11. Chao KC, Yang HT, Chen MW. Human umbilical cord mesenchymal stem cells suppress breast cancer
tumorigenesis through direct cell-cell contact and internalization. J Cell Mol Med. 2011; 16: 1803–1815.
12. Uppalapati D, Ohta N, Zhang Y, Kawabata A, Pyle MM, Becker KG, et al. Identification and Characteri-
zation of Unique Tumoricidal Genes in Rat Umbilical Cord Matrix Stem Cells. Mol Pharm. 2011; 8(5):
1549–1558 doi: 10.1021/mp2001582 PMID: 21851062
13. Kawabata A, Ohta N, Seiler G, Pyle MM, Ishiguro S, Zhang YQ, et al. Naive rat umbilical cord matrix
stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune
responses. Cytotherapy. 2013; 15: 586–597. doi: 10.1016/j.jcyt.2013.01.006 PMID: 23474329
14. Seshareddy K, Troyer D, Weiss ML. Method to isolate mesenchymal-like cells fromWharton's Jelly of
umbilical cord. Methods Cell Biol. 2008; 86: 101–119. doi: 10.1016/S0091-679X(08)00006-X PMID:
18442646
15. Ghorbel MT, Becker KG, Henley JM. Profile of changes in gene expression in cultured hippocampal
neurones evoked by the GABAB receptor agonist baclofen. Physiol Genomics. 2005; 22: 93–98. PMID:
15784695
16. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc.
2008; 3: 1101–1108. PMID: 18546601
Tumor Suppressor Gene Expression in UCMSC
PLOSONE | DOI:10.1371/journal.pone.0123756 May 5, 2015 15 / 17
17. MotomuraW, Inoue M, Ohtake T, Takahashi N, Nagamine M, Tanno S, et al. Up-regulation of ADRP in
fatty liver in human and liver steatosis in mice fed with high fat diet. Biochem Biophys Res Commun.
2006; 340: 1111–1118. PMID: 16403437
18. Pickel L, Matsuzuka T, Doi C, Ayuzawa R, Maurya DK, Xie SX, et al. Over-expression of angiotensin II
type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biol Ther. 2010; 9:
277–285. doi: 10.4161/cbt.9.4.10643 PMID: 20026904
19. Rachakatla RS, Marini F, Weiss ML, Tamura M, Troyer D. Development of human umbilical cord matrix
stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther. 2007; 14: 828–835.
PMID: 17599089
20. Matsuzuka T, Rachakatla RS, Doi C, Maurya DK, Ohta N, Kawabata A, et al. Human umbilical cord ma-
trix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carci-
noma xenografts in SCID mice. Lung Cancer. 2010; 70: 28–36. doi: 10.1016/j.lungcan.2010.01.003
PMID: 20138387
21. Ogino H, Yano S, Kakiuchi S, Muguruma H, Ikuta K, Hanibuchi M, et al. Follistatin suppresses the pro-
duction of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-de-
pleted SCID mice. Clin Cancer Res. 2008; 14: 660–667. doi: 10.1158/1078-0432.CCR-07-1221 PMID:
18245525
22. Seder CW, Hartojo W, Lin L, Silvers AL, Wang Z, Thomas DG, et al. Upregulated INHBA expression
may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia.
2009; 11: 388–396. PMID: 19308293
23. Ying SY, Zhang Z. Expression and localization of inhibin/activin subunits and activin receptors in MCF-
7 cells, a human breast cancer cell line. Breast Cancer Res Treat. 1996; 37: 151–160. PMID: 8750582
24. Leto G, Incorvaia L, Badalamenti G, Tumminello FM, Gebbia N, Flandina C, et al. Activin A circulating
levels in patients with bone metastasis from breast or prostate cancer. Clin Exp Metastasis. 2006; 23:
117–122. PMID: 16841234
25. Krneta J, Kroll J, Alves F, Prahst C, Sananbenesi F, Dullin C, et al. Dissociation of angiogenesis and tu-
morigenesis in follistatin- and activin-expressing tumors. Cancer Res. 2006; 66: 5686–5695. PMID:
16740706
26. Sengupta D, Bhargava DK, Dixit A, Sahoo BS, Biswas S, Mishra SK. ERRbeta signalling through FST
and BCAS2 inhibits cellular proliferation in breast cancer cells. Br J Cancer. 2014; 110: 2144–2158.
doi: 10.1038/bjc.2014.53 PMID: 24667650
27. Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Nakaigawa N, et al. Expression of adipose differentia-
tion-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin Cancer
Res. 2007; 13: 152–160. PMID: 17200350
28. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, et al. ADRP stimulates
lipid accumulation and lipid droplet formation in murine fibroblasts. Am J Physiol Endocrinol Metab.
2002; 283: E775–783. PMID: 12217895
29. Verjans E, Noetzel E, Bektas N, Schutz AK, Lue H, Lennartz B, et al. Dual role of macrophagemigration
inhibitory factor (MIF) in human breast cancer. BMC Cancer. 2009; 9: 230. doi: 10.1186/1471-2407-9-
230 PMID: 19602265
30. Singh-Ranger G, Salhab M, Mokbel K. The role of cyclooxygenase-2 in breast cancer: review. Breast
Cancer Res Treat. 2008; 109: 189–198. PMID: 17624587
31. Ji W, Yang J, Wang D, Cao L, TanW, Qian H, et al. hSulf-1 gene exhibits anticancer efficacy through
negatively regulating VEGFR-2 signaling in human cancers. PLoS One. 2011; 6: e23274. doi: 10.1371/
journal.pone.0023274 PMID: 21853101
32. Bergeron S, Lemieux E, Durand V, Cagnol S, Carrier JC, Lussier JG, et al. The serine protease inhibitor
serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Mol Cancer.
2010; 9: 271. doi: 10.1186/1476-4598-9-271 PMID: 20942929
33. Nagahara A, Nakayama M, Oka D, Tsuchiya M, Kawashima A, Mukai M, et al. SERPINE2 is a possible
candidate promotor for lymph node metastasis in testicular cancer. Biochem Biophys Res Commun.
2010; 391: 1641–1646. doi: 10.1016/j.bbrc.2009.12.105 PMID: 20035713
34. Chien J, Campioni M, Shridhar V, Baldi A. HtrA serine proteases as potential therapeutic targets in can-
cer. Curr Cancer Drug Targets. 2009; 9: 451–468. PMID: 19519315
35. Durchdewald M, Guinea-Viniegra J, Haag D, Riehl A, Lichter P, Hahn M, et al. Podoplanin is a novel
fos target gene in skin carcinogenesis. Cancer Res. 2008; 68: 6877–6883. doi: 10.1158/0008-5472.
CAN-08-0299 PMID: 18757399
36. Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, et al. Extracellular matrix protein betaig-h3/
TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 2008; 22:
308–321. doi: 10.1101/gad.1632008 PMID: 18245446
Tumor Suppressor Gene Expression in UCMSC
PLOSONE | DOI:10.1371/journal.pone.0123756 May 5, 2015 16 / 17
37. Kretschmer C, Conradi A, Kemmner W, Sterner-Kock A. Latent transforming growth factor binding pro-
tein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas. Cell Oncol
(Dordr). 2011; 34: 419–434. doi: 10.1007/s13402-011-0023-y PMID: 21468687
38. Mauel S, Kruse B, Etschmann B, von der Schulenburg AG, Schaerig M, Stövesand K, et al. Latent
transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocar-
cinomas in vitro and in vivo. Apmis. 2007; 115: 687–700. PMID: 17550376
39. ChenWB, LenschowW, Tiede K, Fischer JW, Kalthoff H, Ungefroren H. Smad4/DPC4-dependent reg-
ulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J Biol
Chem. 2002; 277: 36118–36128. PMID: 12140283
40. WuG, Guo Z, Chang X, Kim MS, Nagpal JK, Liu J, et al. LOXL1 and LOXL4 are epigenetically silenced
and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.
Cancer Res. 2007; 67: 4123–4129. PMID: 17456585
Tumor Suppressor Gene Expression in UCMSC
PLOSONE | DOI:10.1371/journal.pone.0123756 May 5, 2015 17 / 17
